Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: London School of Hygiene and Tropical Medicine TB Centre
Street 1: Keppel Street
Street 2:
City: London
Province:
Post Code:
Country: United Kingdom of Great Britain and Northern Ireland
Phone: +44 (0) 20 7636 8636
Email: tb@lshtm.ac.uk
Web Site: http://www.tb.lshtm.ac.uk

Focal Point Contact Information

Salutation: Dr
First Name: Dave
Last Name: Moore
Title: TB Centre Director
Email: david.moore@lshtm.ac.uk
Phone:  

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Maja
Last Name: Niemierko
Title: TB Centre Administrator
Email: tb@lshtm.ac.uk
Phone:  

General Information

Board Constituency: Technical agencies
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
The TB Centre brings together over 120 scientists, doctors, epidemiologists, statisticians, public health officers and policy-makers.

The TB Centre provides a focus for the School's long-established global research expertise in tuberculosis epidemiology, immunology, diagnosis and treatment. It will enable the development of enhanced international partnership, building on the success of 70 existing projects collaborating in more than 40 countries including the UK, South Africa, Uganda, Senegal, Malawi, India, Pakistan, China and Peru.

We are actively encouraging those involved in TB research, clinical practice and public health to make contact with the TB Centre to propose new projects and contribute to existing areas of work
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 100 +
Number of part-time staff who are directly involved with TB: 26 - 50
Number of volunteers who are directly involved with TB: 11 - 25
 
What is your organization's annual budget (USD) dedicated to TB? >$10 MIL
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
The UK lacks a formal NTP - however clinicians working at LSHTM are involved in delivery of TB care in London and contribute to national committees contributing to TB policy for both TB prevention and management.
 

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Bolivia
Cambodia
China
Ghana
India
Indonesia
Kenya
Malawi
Nigeria
Pakistan
Peru
Senegal
Somalia
South Africa
Thailand
Uganda
United Kingdom of Great Britain and Northern Ireland
Viet Nam
Zambia
Zimbabwe

Specializations

Research and Development

Specializations in Countries

Research and Development Bolivia
Research and Development Cambodia
Research and Development China
Research and Development Ghana
Research and Development India
Research and Development Indonesia
Research and Development Kenya
Research and Development Malawi
Research and Development Nigeria
Research and Development Pakistan
Research and Development Peru
Research and Development Senegal
Research and Development Somalia
Research and Development South Africa
Research and Development Thailand
Research and Development Uganda
Research and Development United Kingdom of Great Britain and Northern Ireland
Research and Development Viet Nam
Research and Development Zambia
Research and Development Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
diagnosis, through MODS and Xpert related studies in Latin America and southern Africa
treatment through collaboration with institutions undertaking clinical trials

TB-HIV:
multiple large scale trials in southern Africa evaluating active case finding and preventive therapy approaches for targeted risk-groups and at population level

New Diagnostics:
phenotypic, genotypic and antigen test development, evaluation and implementation research

New TB Vaccines:
immunological and biomarker research as part of large vaccine consortia

Research:
Xpert implementation evaluation research in southern Africa
TANDEM consortium to evaluate interface between TB and diabetes melllitus

Declaration

Declaration of interests:
none to declare

Application date: July 24, 2013
Last updated: June 19, 2014